Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC education efforts for Questran would stress physician consultation, BMS says.

This article was originally published in The Tan Sheet

Executive Summary

OTC QUESTRAN AD CAMPAIGN WOULD STRESS PHYSICIAN CONSULTATION as part of a three-step approach to cholesterol lowering, Bristol-Myers Products President Sion Boney reported during a May 13 meeting of FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs Advisory Committees to consider the Rx-to-OTC switch of Questran (cholestyramine). "Everything that we [will] say in advertising has a clear message: consult your physician first -- that is the most important step," Boney emphasized.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel